Major Drugs - Platte City, MO, US
LPOXY Therapeutics, Inc is a privately held biopharmaceutical company developing a non-antibiotic, non-vaccine, first-in-class therapeutic modality to prevent infections by C. difficile, a CDC urgent priority pathogen. LPOXY's huge addressable target market, value-pricing, and limited competition uniquely situates LPOXY for success in the antibacterial space. We have built an industry-leading team with expertise in drug development and regulatory affairs.
Squarespace ECommerce
Gmail
Google Font API
Google Plus
Mobile Friendly